Izydorczyk, M. S., McMillan, T., Bazin, S., Kletke, J., Dushnicky, L., Dexter, J., Chepurna, A. and Rossnagel, B. 2014. Milling of Canadian oats and barley for functional food ingredients: Oat bran and barley fibre-rich fractions. Can. J. Plant Sci. 94: 573-586. Oats and barley are recognized for their valuable fibre constituents having protective and therapeutic effects against the development of diet-related disorders. Mixed linkage (1-3), (1-4)-β-D-glucans, the major dietary fibre constituents in oats and barley, have been linked to blood cholesterol lowering properties of these grains. The objective of this study was to compare oat bran and barley fibre-rich fractions (FRF) as two products with elevated levels of β-glucans and obtained by similar roller milling processes. The content of β-glucan in oat brans prepared from three different cultivars (AC Morgan, HiFi, and CDC ProFi) ranged from 7.90 to 9.50%, whereas the content of β-glucans in FRF prepared from three barley cultivars (CDC McGwire, CDC Fibar, and CDC Hilose) ranged from 9.31 to 18.19% (dwb). The yields of oat brans ranged from 44 to 49% and the yields of barley FRF from 39-49%. Both preparations contained higher amounts of arabinoxylans, proteins, and ash compared with the original grains. The oat brans were made up mainly of fragments containing the outer grain layers with a substantial portion of the subaleurone starchy endosperm attached to them, whereas the barley FRF consisted primarily of fragments containing the endosperm cell walls, with a smaller proportion of the outer grain tissues. The barley FRF contained smaller particles with broader distribution of particle size than the oat brans. The oat bran particles had higher bulk density and lower porosity than the barley FRF. Both preparations showed pronounced viscosity-building properties when dispersed in water at 45°C, but exhibited different viscosity profiles and differences in the attainable viscosity values.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 94 • No. 3